卒中相关性肺炎的危险因素及诊疗研究进展
Research Progress on Risk Factors and Diagnosis and Treatment of Stroke-Associated Pneumonia
摘要: 脑卒中具有发病率高、致残率高、死亡率高等特点，对人类生命健康有着重大威胁，而卒中相关性肺炎是脑卒中后最常见并发症之一，因其危险因素较多，故治疗难度比单纯脑卒中患者更大，预后也更差。随着医疗技术不断发展，国内外关于卒中相关性肺炎的报道不断增多，但缺乏一致性及整体性，本文就文献中所报道的卒中相关性肺炎危险因素及诊疗进行综述，以求在临床治疗卒中相关性肺炎患者时作相关参考。
Abstract: Stroke has the characteristics of high morbidity, high disability rate and high mortality, posing a major threat to human life and health. Stroke-related pneumonia is one of the most common complications after stroke. Due to its many risk factors, it is more difficult to treat than patients with stroke alone and the prognosis is worse. With the continuous development of medical technology, reports on stroke-associated pneumonia are increasing at home and abroad, but lack consistency and integrity. This paper reviews the risk factors and diagnosis and treatment of stroke-associated pneumonia reported in the literature, in order to provide relevant reference for clinical treatment of patients with stroke-associated pneumonia.
文章引用：裴梦鸽, 孙薇陶, 李古强. 卒中相关性肺炎的危险因素及诊疗研究进展[J]. 临床医学进展, 2021, 11(11): 4883-4888. https://doi.org/10.12677/ACM.2021.1111717

参考文献

[1] 江滨. 现阶段我国脑卒中流行特征及防治现状对全科医疗服务的启示和建议[J]. 中国全科医学, 2019, 22(30): 3653-3661.
[2] Ji, R., Wang, D., Shen, H., et al. (2013) Interrelationship among Common Medical Complications after Acute Stroke: Pneumonia Plays an Important Role. Stroke, 44, 3436-3444. [Google Scholar] [CrossRef] 
[3] Hilker, R., Poetter, C., Findeisen, N., et al. (2003) Nosocomial Pneumonia after Acute Stroke. Stroke, 34, 975-981. [Google Scholar] [CrossRef] 
[4] 王拥军, 陈玉国, 吕传柱, 等. 卒中相关性肺炎诊治中国专家共识(2019更新版) [J]. 中国卒中杂志, 2019, 14(12): 1251-1262.
[5] 贺玉婷, 吴波. 卒中相关性肺炎的危险因素研究[J]. 华西医学, 2021, 36(5): 638-642.
[6] Sui, R. and Zhang, L. (2013) Risk Factors of Stroke-Associated Pneumonia in Chinese Patients. Neurological Research, 33, 508-513. [Google Scholar] [CrossRef] 
[7] Mostafa, G., Huynh, T., Sing, R.F., et al. (2002) Gender-Related Outcomes in Trauma. The Journal of Trauma, 53, 430-435. [Google Scholar] [CrossRef] [PubMed]
[8] Dziedzic, T., Pera, J., Wnuk, M., et al. (2012) Serum Albumin as a Determinant of Cortisol Release in Patients with Acute Ischemic Stroke. Atherosclerosis, 221, 212-214. [Google Scholar] [CrossRef] [PubMed]
[9] The, W.H., Smith, C.J., Barlas, R.S., et al. (2018) Impact of Stroke-Associated Pneumonia on Mortality, Length of Hospitalization, and Functional Outcome. Acta Neurologica Scandinavica, 138, 293-300. [Google Scholar] [CrossRef] [PubMed]
[10] 杨敏京, 冯立群. 老年脑梗死患者合并卒中相关性肺炎的危险因素与病原学分析[J]. 慢性病学杂志, 2021, 22(6): 840-844.
[11] Han, T.S., Fry, C.H., Fluck, D., et al. (2017) Evaluation of Anticoagulation Status for Atrial Fibrillation on Early Ischaemic Stroke Outcomes: A Registry-Based, Prospective Cohort Study of Acute Stroke Care in Surrey, UK. BMJ Open, 7, e19122. [Google Scholar] [CrossRef] [PubMed]
[12] 张洋洋, 莫延红, 张兆辉. 脑卒中相关性肺炎的研究进展[J]. 卒中与神经疾病, 2020, 27(2): 259-263.
[13] Luitse, M.J., Velthuis, B.K., Kappelle, L.J., et al. (2017) Chronic Hyperglycemia Is Related to Poor Functional Outcome after Acute Ischemic Stroke. International Journal of Stroke, 12, 180-186. [Google Scholar] [CrossRef] [PubMed]
[14] Sellars, C., Bowie, L., Bagg, J., et al. (2007) Risk Factors for Chest Infection in Acute Stroke. Stroke, 38, 2284-2291. [Google Scholar] [CrossRef] 
[15] Walter, U., Kolbaske, S., Patejdl, R., et al. (2013) Insular Stroke Is Associated with Acute Sympathetic Hyperactivation and Immunodepression. European Journal of Neurology, 20, 153-159. [Google Scholar] [CrossRef] [PubMed]
[16] Hadley, A.J., Thompson, P., Kolb, I., et al. (2014) Targeted Transtracheal Stimulation for Vocal Fold Closure. Dysphagia, 29, 346-354. [Google Scholar] [CrossRef] [PubMed]
[17] Vogelgesang, A., Grunwald, U., Langner, S., et al. (2008) Analysis of Lymphocyte Subsets in Patients with Stroke and Their Influence on Infection after Stroke. Stroke, 39, 237-241. [Google Scholar] [CrossRef] 
[18] Kalra, L., Irshad, S., Hodsoll, J., et al. (2015) Prophylactic Antibiotics after Acute Stroke for Reducing Pneumonia in Patients with Dysphagia (STROKE-INF): A Prospective, Cluster-Randomised, Open-Label, Masked Endpoint, Controlled Clinical Trial. The Lancet, 386, 1835-1844. [Google Scholar] [CrossRef] 
[19] Westendorp, W.F., Vermeij, J., Zock, E., et al. (2015) The Preventive Antibiotics in Stroke Study (PASS): A Pragmatic Randomised Open-Label Masked Endpoint Clinical Trial. The Lancet, 385, 1519-1526. [Google Scholar] [CrossRef] 
[20] 郑卫涛, 陈家俊, 杜龙玉, 等. 中医药治疗卒中相关性肺炎研究进展[J]. 新中医, 2021, 53(4): 25-28.
[21] 程丽, 顾岩, 徐磊, 等. 痰热清注射液联合抗生素对脑卒中并发肺部感染患者的治疗效果[J]. 中华医院感染学杂志, 2019, 29(24): 3769-3772.
[22] 史雁. 醒脑静辅助治疗卒中相关性肺炎的疗效[J]. 实用临床医学, 2011, 12(4): 23-25.
[23] 周敏. 血必净注射液联合盐酸氨溴索对脑卒中相关性肺炎患者炎性因子水平及预后的影响[J]. 药物评价研究, 2019, 42(11): 2206-2209.
[24] 张莉婷, 阳艳. 间歇雾化吸入联合机械排痰对卒中相关性肺炎护理疗效观察[J]. 医学理论与实践, 2017, 30(24): 3716-3717.
[25] 丘伟杰, 池伟文, 周向军. 应用纤维支气管镜加强吸痰对卒中相关性肺炎的疗效观察[J]. 现代医药卫生, 2021, 37(7): 1153-1155.
[26] 朱允和, 马路景. 体外膈肌起搏在临床疾病中的研究进展[J]. 中国继续医学教育, 2021, 13(22): 117-120.
[27] 朱小群. 超短波联合常规排痰护理治疗卒中相关性肺炎的临床疗效观察[J]. 临床医药文献电子杂志, 2020, 7(89): 84-85.

为你推荐